| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BUB1 mitotic checkpoint serine/threonine kinase | 0.528 | 0.731 | 4.9E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
C-C motif chemokine ligand 17 | 0.518 | 0.808 | 1.4E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
C-C motif chemokine ligand 22 | 0.500 | 0.846 | 8.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
C-type lectin domain family 12 member A | 0.686 | 0.346 | 2.6E-07 |
|
disease | 0.100 | None | 0.950 | 1 | 0 | 2004 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
calcium modulating ligand | 0.769 | 0.154 | 6.2E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2003 | 2004 | ||||||||
|
CASP8 and FADD like apoptosis regulator | 0.485 | 0.846 | 1.00 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2013 | ||||||||
|
cathelicidin antimicrobial peptide | 0.466 | 0.846 | 4.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cathepsin G | 0.563 | 0.731 | 9.6E-06 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 | 0.638 | 0.462 | 4.8E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 12 | 0 | 1992 | 2020 | ||||||||
|
CCAAT enhancer binding protein delta | 0.570 | 0.769 | 0.61 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
CCAAT enhancer binding protein epsilon | 0.674 | 0.385 | 7.1E-03 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1988 | 2019 | ||||||||
|
CD244 molecule | 0.653 | 0.500 | 5.7E-02 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
CD33 molecule | 0.524 | 0.769 | 5.7E-07 |
|
disease | 0.400 | None | 0.958 | 1 | 0 | 1991 | 2020 |